|
|||||
|
|
Impact of the COVID-19 pandemic on people living with migraine: Results of the MiCOAS qualitative study |
|
| Authors: | Dawn C Buse PhD Maya T Gerstein DrPH Carrie R Houts PhD James S McGinley PhD Alyssa A Uzumcu BA Kelly P McCarrier PhD Alexis Cooke PhD Nancy M Touba MPH Tracy K Nishida PhD R J Wirth PhD Richard B Lipton MD |
| Institution: | 1. Vector Psychometric Group, LLC, Chapel Hill, North Carolina, USA;2. Patient Centered Outcomes, Open Health Group, Bethesda, Maryland, USA;3. Neurology, Albert Einstein College of Medicine, Bronx, New York, USA
Headache, Montefiore Medical Center, Bronx, New York, USA |
| Abstract: | |
| Keywords: | coronavirus disease 2019 (COVID-19) Food and Drug Administration impact migraine pandemic qualitative |